Chongqing Genrix Biopharmaceutical Co (SHSE:688443) 5-Day RSI: 70.85 (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688443 Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
29 GF Score
Price ¥26.36
! 4 Warning Signs
View Full Analysis

What is Chongqing Genrix Biopharmaceutical Co 5-Day RSI?

Chongqing Genrix Biopharmaceutical Co SHSE:688443 -1.49% 29 5-Day RSI is 70.85 as of Aug. 15, 2026. GuruFocus rates SHSE:688443 with a GF Score™ of 29/100. The stock has 4 warning signs investors should review. Among 1,417 Biotechnology companies, Chongqing Genrix Biopharmaceutical Co ranks worse than 88.85% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-08-15), Chongqing Genrix Biopharmaceutical Co's 5-Day RSI is 70.85.

The industry rank for Chongqing Genrix Biopharmaceutical Co's 5-Day RSI or its related term are showing as below:

SHSE:688443's 5-Day RSI is ranked worse than
88.85% of 1417 companies
in the Biotechnology industry
Industry Median: 55.09 vs SHSE:688443: 70.85

Chongqing Genrix Biopharmaceutical Co  (SHSE:688443) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Chongqing Genrix Biopharmaceutical Co 5-Day RSI Related Terms


SHSE:688443 vs VRTX, REGN, RVMD: 5-Day RSI Comparison

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Genrix Biopharmaceutical Co 5-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's 5-Day RSI falls into.


SHSE:688443
29GF Score
Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
5-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Genrix Biopharmaceutical Co  (SHSE:688443) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 5-Day RSI →
What does a 5-Day RSI of 70.85 mean?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a 5-Day RSI of 70.85 as of Aug. 15, 2026. According to the industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #1259 out of 1417 companies in the Biotechnology industry, placing it in the top 88.8%.
Is Chongqing Genrix Biopharmaceutical Co's 5-Day RSI too high?
Chongqing Genrix Biopharmaceutical Co's current 5-Day RSI is 70.85. The Biotechnology industry median 5-Day RSI is 55.09. Chongqing Genrix Biopharmaceutical Co's value of 70.85 is 28.6% above this industry median. Based on the distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #1259 out of 1417 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chongqing Genrix Biopharmaceutical Co has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Chongqing Genrix Biopharmaceutical Co's 5-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #1259 out of 1417 companies for 5-Day RSI. This places Chongqing Genrix Biopharmaceutical Co in the lower half of its industry. The industry median 5-Day RSI is 55.09. Chongqing Genrix Biopharmaceutical Co's value of 70.85 is 28.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Biotechnology company?
The median 5-Day RSI among Biotechnology companies is 55.09, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Genrix Biopharmaceutical Co's current 5-Day RSI of 70.85 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 5-Day RSI is 55.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Genrix Biopharmaceutical Co's current 5-Day RSI is 70.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Genrix Biopharmaceutical Co stock overvalued right now?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a current 5-Day RSI of 70.85. The current 5-Day RSI is 70.85 and 28.6% above the Biotechnology industry median of 55.09. Chongqing Genrix Biopharmaceutical Co's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Chongqing Genrix Biopharmaceutical Co (SHSE:688443), the current 5-Day RSI is 70.85 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chongqing Genrix Biopharmaceutical Co Business Description

Address No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan District, Chongqing, CHN, 401338
Chongqing Genrix Biopharmaceutical Co Ltd is a biopharmaceutical company engaged in the research & development, production and sales of antibody drugs. The company's pipeline includes product candidate that targets Autoimmune Diseases, Infectious Diseases, and Oncology.
29GF Score

Get the complete analysis for SHSE:688443

5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.36
Price